Paul‐Joseph Aspuria

1.1k total citations
22 papers, 808 citations indexed

About

Paul‐Joseph Aspuria is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Paul‐Joseph Aspuria has authored 22 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Paul‐Joseph Aspuria's work include CAR-T cell therapy research (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Paul‐Joseph Aspuria is often cited by papers focused on CAR-T cell therapy research (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Paul‐Joseph Aspuria collaborates with scholars based in United States, Sweden and Japan. Paul‐Joseph Aspuria's co-authors include Fuyuhiko Tamanoi, Beth Y. Karlan, Sandra Oršulić, W. Ruprecht Wiedemeyer, Jessica A. Beach, Dong‐Joo Cheon, Maricel Gozo, Christine Walsh, Hasmik Agadjanian and Jens Nielsen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Paul‐Joseph Aspuria

21 papers receiving 805 citations

Peers

Paul‐Joseph Aspuria
Zhiming Zhang China
Samah El Ghamrasni Canada
Tewfik Hamidi France
Toshinori Hyodo Japan
Sónia Moniz Portugal
Shikha Sharan United States
Chiara Naro Italy
Joffrey Pelletier Spain
Nathalie Delvoye Canada
Inken Wierstra Germany
Zhiming Zhang China
Paul‐Joseph Aspuria
Citations per year, relative to Paul‐Joseph Aspuria Paul‐Joseph Aspuria (= 1×) peers Zhiming Zhang

Countries citing papers authored by Paul‐Joseph Aspuria

Since Specialization
Citations

This map shows the geographic impact of Paul‐Joseph Aspuria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul‐Joseph Aspuria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul‐Joseph Aspuria more than expected).

Fields of papers citing papers by Paul‐Joseph Aspuria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul‐Joseph Aspuria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul‐Joseph Aspuria. The network helps show where Paul‐Joseph Aspuria may publish in the future.

Co-authorship network of co-authors of Paul‐Joseph Aspuria

This figure shows the co-authorship network connecting the top 25 collaborators of Paul‐Joseph Aspuria. A scholar is included among the top collaborators of Paul‐Joseph Aspuria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul‐Joseph Aspuria. Paul‐Joseph Aspuria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Aspuria, Paul‐Joseph, Ivan Cheng, Navneet Ratti, et al.. (2023). 228 Engineered human IL-2/IL-2Rß orthogonal pairs selectively enhance anti-GPC3 CAR T cells in vivo to drive complete responses in solid epithelial tumor models. SHILAP Revista de lepidopterología. A260–A260. 1 indexed citations
4.
Oft, Martin, Navneet Ratti, Sandro Vivona, et al.. (2023). Abstract 1801: STK-012, an a/b-selective IL-2 activates tumor antigen specific CD25+ CD8 T cells to reject tumors without acute vascular toxicity. Cancer Research. 83(7_Supplement). 1801–1801. 1 indexed citations
5.
Aspuria, Paul‐Joseph, Sandro Vivona, Navneet Ratti, et al.. (2022). Abstract 2824: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance anti-GPC3 CAR T cells to drive complete responses in solid epithelial tumor models. Cancer Research. 82(12_Supplement). 2824–2824.
6.
Aspuria, Paul‐Joseph, Sandro Vivona, Michele Bauer, et al.. (2021). An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma. Science Translational Medicine. 13(625). eabg7565–eabg7565. 61 indexed citations
7.
Dinh, Huy Q., Xianzhi Lin, Forough Abbasi, et al.. (2021). Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube. Cell Reports. 35(2). 108978–108978. 50 indexed citations
8.
Emmerich, Jan, Michele Bauer, Bhargavi Jayaraman, et al.. (2021). Abstract 1744: STK-012, an alpha/beta selective IL-2 mutein for the activation of the antigen-activated T cells in solid tumor. Cancer Research. 81(13_Supplement). 1744–1744. 13 indexed citations
9.
Aspuria, Paul‐Joseph, Dong‐Joo Cheon, Maricel Gozo, et al.. (2020). HOXB13 controls cell state through super-enhancers. Experimental Cell Research. 393(1). 112039–112039. 9 indexed citations
10.
Aspuria, Paul‐Joseph, Michael Bauer, Sandro Vivona, et al.. (2020). OrthoCARs: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance CAR T cell antitumorefficacy. Blood. 136(Supplement 1). 35–35. 1 indexed citations
11.
Aspuria, Paul‐Joseph, Barbie Taylor‐Harding, Lindsay Spurka, et al.. (2017). Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT. Oncotarget. 8(16). 26200–26220. 36 indexed citations
12.
Beach, Jessica A., Paul‐Joseph Aspuria, Dong‐Joo Cheon, et al.. (2015). Sphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancer. Oncotarget. 7(4). 4167–4182. 48 indexed citations
13.
Beach, Jessica A., Paul‐Joseph Aspuria, Dong‐Joo Cheon, et al.. (2015). Abstract B09: Sphingosine kinase 1 (SPHK1) is a novel mediator of tumor-stroma interaction in ovarian cancer. Cancer Research. 75(1_Supplement). B09–B09. 1 indexed citations
14.
Aspuria, Paul‐Joseph, Sophia Y. Lunt, Leif Väremo, et al.. (2014). Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism. Cancer & Metabolism. 2(1). 21–21. 136 indexed citations
15.
Taylor‐Harding, Barbie, Paul‐Joseph Aspuria, Hasmik Agadjanian, et al.. (2014). Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS. Oncotarget. 6(2). 696–714. 88 indexed citations
16.
Xing, Deyin, Mai Nitta, Lei He, et al.. (2009). A Role for BRCA1 in Uterine Leiomyosarcoma. Cancer Research. 69(21). 8231–8235. 47 indexed citations
17.
Aspuria, Paul‐Joseph & Fuyuhiko Tamanoi. (2008). The Tsc/Rheb signaling pathway controls basic amino acid uptake via the Cat1 permease in fission yeast. Molecular Genetics and Genomics. 279(5). 441–450. 33 indexed citations
18.
Aspuria, Paul‐Joseph, Tatsuhiro Sato, & Fuyuhiko Tamanoi. (2007). The TSC/Rheb/TOR Signaling Pathway in Fission Yeast and Mammalian Cells: Temperature Sensitive and Constitutive Active Mutants of TOR. Cell Cycle. 6(14). 1692–1695. 33 indexed citations
19.
Urano, Jun, Lea Guo, Paul‐Joseph Aspuria, et al.. (2005). Identification of novel single amino acid changes that result in hyperactivation of the unique GTPase, Rheb, in fission yeast. Molecular Microbiology. 58(4). 1074–1086. 73 indexed citations
20.
Aspuria, Paul‐Joseph & Fuyuhiko Tamanoi. (2004). The Rheb family of GTP-binding proteins. Cellular Signalling. 16(10). 1105–1112. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiming Zhang Breakdown of academic impact, for papers by Samah El Ghamrasni Breakdown of academic impact, for papers by Tewfik Hamidi Breakdown of academic impact, for papers by Toshinori Hyodo Breakdown of academic impact, for papers by Sónia Moniz Breakdown of academic impact, for papers by Shikha Sharan Breakdown of academic impact, for papers by Chiara Naro Breakdown of academic impact, for papers by Joffrey Pelletier Breakdown of academic impact, for papers by Nathalie Delvoye Breakdown of academic impact, for papers by Inken Wierstra
Rankless by CCL
2026